Home > Field of Cooperation > Health Research > Long-term immunity to SARS-CoV-2 in influencing COVID-19 disease outcome in Asia
Long-term immunity to SARS-CoV-2 in influencing COVID-19 disease outcome in Asia |
| Principal Investigator / Affiliation | Meng Ling Moi (Professor) / Nagasaki University  Japan |
|---|---|
Sujan Shresta (Associate Professor) / La Jolla Institute for Immunology  USA |
|
Thi Quynh Mai Le (Vice Director) / National Institute of Hygiene and Epidemiology  Vietnam |
|
Kathryn Roa (Infectious Disease Specialist) / Southern Philippines Medical Center  Philippines |
|
| Year Adopted | 2020 |
| Research Period | 2 years |
| General Description of the Research Project | This cooperative research project aims to decipher how immunity in SARS-CoV-2 virus infection modulates disease manifestations and whether viral genetic diversity is associated with disease outcomes and infectivity across Southeast and East Asia. In addition, this project seeks to identify novel broadly neutralizing antibodies against SARS-CoV-2 for the development of innovative diagnostics and therapeutics. |
| Photo Gallery | |
| Reports | |
| Links |
Researchers
| Principal Investigator / Country of Research Team | 
Meng Ling Moi Japan
Sujan Shresta the United States
Thi Quynh Mai Le Vietnam
Kathryn Roa the Philippines |
|---|